CORT logo

Corcept Therapeutics Inc.

CORT

CORT: Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic and neuropsychiatric disorders by modulating the effect of the hormone cortisol.

more

Show CORT Financials

Chart and Financial Data provided by TradingView

All
Government
Consumer Interest
SEC Filings
ESG/Other
Congress Trading

Recent trades of CORT by members of U.S. Congress

Quiver Logo

No Congress Trading data for this ticker

Congress Trading Dashboard
Whale Activity

Recently reported changes by institutional investors

Insider Trading

Quarterly net insider trading by CORT's directors and management

Corporate Lobbying

Government lobbying spending instances

Quiver Logo

No Corporate Lobbying instances for this ticker

Corporate Lobbying Dashboard
U.S. Patents

New patents grants

  • Patent Title: Polymorphs of pyrimidine cyclohexyl glucocorticoid receptor modulators Sep. 19, 2023
  • Patent Title: Use of cortisol in assessment and prophylactic treatment of hypokalemia associated with glucocorticoid receptor modulator treatment of cushing's syndrome patients Sep. 05, 2023
  • Patent Title: Therapeutic uses of relacorilant, a heteroaryl-ketone fused azadecalin glucocorticoid receptor modulator Jun. 27, 2023
  • Patent Title: Glucocorticoid receptor modulators to treat cervical cancer May. 30, 2023
  • Patent Title: Heteroaryl-ketone fused azadecalin glucocorticoid receptor modulators May. 16, 2023
  • Patent Title: Glucocorticoid receptor modulators to treat pancreatic cancer May. 09, 2023
  • Patent Title: Systems and methods of managing treatment of a chronic condition by symptom tracking Mar. 21, 2023
  • Patent Title: Fatty liver disease treatment using glucocorticoid and mineralocorticoid receptor antagonists Feb. 28, 2023
  • Patent Title: Therapeutic uses of relacorilant, a heteroaryl-ketone fused azadecalin glucocorticoid receptor modulator Feb. 28, 2023
  • Patent Title: Heteroaryl-ketone fused azadecalin glucocorticoid receptor modulators Feb. 14, 2023
  • Patent Title: Octahydro fused azadecalin glucocorticoid receptor modulators Jan. 24, 2023
  • Patent Title: Polymorphs of pyrimidine cyclohexyl glucocorticoid receptor modulators Jan. 10, 2023
  • Patent Title: Pyrimidine cyclohexenyl glucocorticoid receptor modulators Jan. 03, 2023
  • Patent Title: Treatment of hypercoagulopathy in cushing's syndrome by administration of glucocorticoid receptor modulators Dec. 13, 2022
  • Patent Title: Pharmaceutical formulations containing relacorilant, a heteroaryl-ketone fused azadecalin compound Oct. 11, 2022
  • Patent Title: Methods of treating cancer comprising administration of a glucocorticoid receptor modulator and a cancer chemotherapy agent Jul. 19, 2022
  • Patent Title: Octahydro fused azadecalin glucocorticoid receptor modulators Jun. 28, 2022
  • Patent Title: Treatment and differential diagnosis of cushing's disease and ectopic cushing's syndrome May. 10, 2022
  • Patent Title: Concomitant administration of glucocorticoid receptor modulator relacorilant and paclitaxel, a dual substrate of cyp2c8 and cyp3a4 Mar. 29, 2022
  • Patent Title: Methods for treating cushing's syndrome Mar. 08, 2022
  • Patent Title: Methods of treating cancer comprising administration of a glucocorticoid receptor modulator and a cancer chemotherapy agent Feb. 01, 2022
  • Patent Title: Methods of treating neuroepithelial tumors using selective glucocorticoid receptor modulators Jan. 04, 2022
  • Patent Title: Use of acth in assessment and prophylactic treatment of hypokalemia associated with glucocorticoid receptor modulator treatment of cushing's syndrome patients Dec. 21, 2021
  • Patent Title: Use of glucocorticoid receptor antagonists in combination with glucocorticoids to treat adrenal insufficiency Dec. 21, 2021
  • Patent Title: Optimizing mifepristone levels for cushing's patients Nov. 16, 2021
  • Patent Title: Treatment of muscular dystrophy Aug. 31, 2021
  • Patent Title: Method for differentially diagnosing acth-dependent cushing's syndrome Jul. 27, 2021
  • Patent Title: Therapeutic uses of relacorilant, a heteroaryl-ketone fused azadecalin glucocorticoid receptor modulator Jul. 13, 2021
  • Patent Title: Use of glucocorticoid receptor modulators in the treatment of catecholamine-secreting tumors Jun. 29, 2021
  • Patent Title: Use of glucocorticoid receptor modulators to potentiate checkpoint inhibitors Apr. 20, 2021
  • Patent Title: Heteroaryl-ketone fused azadecalin glucocorticoid receptor modulators Apr. 13, 2021
  • Patent Title: Systems and methods of treatment using intervention and tasking determination Mar. 16, 2021
  • Patent Title: Methods for shrinking pituitary tumors Mar. 16, 2021
  • Patent Title: Glucocorticoid receptor modulators to treat cervical cancer Jan. 26, 2021
  • Patent Title: Fatty liver disease treatment using glucocorticoid and mineralocorticoid receptor antagonists Jan. 05, 2021
  • Patent Title: Optimizing mifepristone absorption Nov. 24, 2020
  • Patent Title: Concomitant administration of glucocorticoid receptor modulators and cyp3a inhibitors Nov. 24, 2020
  • Patent Title: Glucocorticoid receptor modulators to treat pancreatic cancer Nov. 10, 2020
  • Patent Title: Octahydro fused azadecalin glucocorticoid receptor modulators Sep. 29, 2020
  • Patent Title: Use of cortisol in assessment and prophylactic treatment of hypokalemia associated with glucocorticoid receptor modulator treatment of cushing's syndrome patients Sep. 22, 2020
  • Patent Title: Optimizing mifepristone levels for cushing's patients May. 26, 2020
  • Patent Title: Glucocorticoid receptor modulators to treat pancreatic cancer May. 12, 2020
  • Patent Title: Glucocorticoid receptor modulators to treat cervical cancer Feb. 25, 2020
  • Patent Title: Optimizing mifepristone absorption Dec. 10, 2019
  • Patent Title: Method for differentially diagnosing acth-dependent cushing's syndrome Dec. 03, 2019
  • Patent Title: Methods of preparing regioselective n-alkyl triazoles Dec. 03, 2019
  • Patent Title: Heteroaryl-ketone fused azadecalin glucocorticoid receptor modulators Oct. 29, 2019
  • Patent Title: Glucocorticoid receptor modulators to treat pancreatic cancer Oct. 22, 2019
  • Patent Title: Glucocorticoid receptor modulators to treat cervical cancer Sep. 17, 2019
  • Patent Title: Octahydro fused azadecalin glucocorticoid receptor modulators Jun. 18, 2019
Government Contracts

Federal grants, loans, and purchases

Quiver Logo

No Government Contracts for this ticker

Government Contracts Dashboard
WallStreetBets

Number of mentions of CORT in WallStreetBets Daily Discussion

CORT News

Recent insights relating to CORT

CNBC Recommendations

Recent picks made for CORT stock on CNBC

Top ETF Holders

ETFs with the largest estimated holdings in CORT

Corporate Flights

Flights by private jets registered to CORT